TickerGuard
Buy Day today: Neutral (57) Mixed market breadth · no major macro event
BKD

Brookdale Senior Living Inc

Healthcare · Medical Care Facilities

10.10$ -7.1% vs. previous close Closing price · As of: Oct 9, 2026

Statements

Balance Sheet

Brookdale Senior Living Inc (BKD) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 5,902 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet BKD
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
9,632 9,218 8,238 8,193 8,092 7,675 7,187 6,730 6,495 6,467 7,631 7,459 7,374 7,194 7,502 7,425 7,008 6,902 6,746 6,603 6,654 6,410 6,295 6,168 6,094 5,937 5,886 5,905 5,829 5,573 5,542 5,451 5,939 6,336 6,206 6,141 6,013 5,952 5,898 5,902
554 620 474 561 936 902 892 551 637 774 751 656 629 596 802 838 722 774 857 781 833 699 655 587 581 637 666 617 594 478 516 493 474 513 454 467 537 554 553 597
74 216 59 152 292 223 335 127 134 398 257 256 241 240 393 452 355 380 304 281 479 347 289 239 299 399 362 337 332 278 319 290 255 309 240 252 253 279 265 370
74 216 59 181 538 514 510 147 134 413 340 315 291 309 501 562 491 553 439 381 636 529 469 404 389 448 431 433 398 308 319 310 284 329 240 252 253 279 270 390
135 142 138 130 131 129 125 118 130 134 138 138 141 134 136 121 114 109 53 53 52 51 50 50 52 56 53 48 48 48 50 50 53 52 58 56 68 68 64 56
212 131 136 129 150 144 121 180 284 121 87 73 94 70 61 66 44 44 274 269 49 30 0.0 – 0.0 28 53 35 54 41 46 – – – – – – – – –
7,622 7,379 6,512 6,424 6,180 5,852 5,775 5,716 5,407 5,275 5,236 5,214 6,407 6,270 6,379 6,287 5,970 5,856 5,762 5,691 5,610 5,535 5,463 5,412 5,341 5,133 5,059 5,136 5,080 – – – 5,374 5,728 5,654 5,580 5,376 5,305 – –
697 705 711 711 506 506 154 154 154 154 154 154 154 154 154 154 154 154 27 27 27 27 27 27 27 27 27 27 27 27 27 27 27 27 27 27 27 27 27 27
114 83 82 80 65 68 61 60 60 51 46 43 43 35 317 317 310 34 306 4,985 4,941 4,904 4,874 4,840 4,802 4,536 – – – – – – – 244 281 279 268 231 256 258
7,282 7,140 6,283 6,277 6,582 6,145 6,108 5,809 5,605 5,449 6,713 6,593 6,580 6,496 6,449 6,485 6,164 6,099 6,051 5,987 5,861 5,711 5,696 5,650 5,601 5,353 5,345 5,365 5,336 5,168 5,167 5,109 5,645 6,122 6,058 6,035 6,018 5,996 5,952 5,929
800 731 706 1,078 1,128 1,096 1,064 736 963 773 1,102 970 1,058 1,047 686 930 719 691 899 897 822 632 793 854 657 641 707 649 898 600 614 622 584 580 556 566 638 153 161 522
265 215 234 675 739 603 605 279 504 318 862 763 847 596 286 451 237 235 385 382 387 234 384 446 243 267 290 243 496 235 263 261 203 189 167 152 186 153 161 152
71 77 64 78 77 92 73 80 80 95 85 104 106 105 78 62 63 71 65 75 74 76 82 77 78 71 89 95 77 67 74 75 73 66 73 83 85 75 84 83
3,543 3,414 3,389 3,042 3,384 3,375 3,343 3,471 3,212 3,346 3,188 3,305 3,229 3,216 3,811 3,636 3,858 3,847 3,665 3,655 3,638 3,778 3,641 3,566 3,759 3,784 3,772 3,761 3,493 3,656 3,692 3,679 3,654 4,022 4,248 4,232 4,159 4,215 4,224 4,225
2,351 2,078 1,955 1,916 1,510 1,531 1,080 921 890 1,019 918 861 788 696 1,050 938 842 800 693 614 792 697 597 516 491 583 539 538 492 404 374 340 293 212 147 105 -6.7 -45 -56 -29
-1,701 -1,970 -2,096 -2,142 -2,556 -2,541 -2,998 -3,164 -3,201 -3,069 -3,168 -3,223 -3,302 -3,393 -3,024 -3,142 -3,267 -3,311 -3,419 -3,503 -3,329 -3,410 -3,510 -3,595 -3,623 -3,649 -3,693 -3,698 -3,747 -3,838 -3,867 -3,905 -3,956 -4,040 -4,105 -4,148 -4,263 -4,303 -4,309 -4,286
186 186 186 186 186 187 187 188 188 188 187 186 186 185 185 183 183 183 184 185 196 185 186 187 187 202 225 225 225 225 226 227 228 229 231 233 234 234 238 244

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?